OBIO Orchestra BioMed Holdings Inc
186
$4.88
$0.10
(2.01%)
| Watchers | 186 |
| 52-Wk Low | $4.22 |
| 52-Wk High | $20.19 |
| Market Cap | $174.64M |
| Volume | 16,442.00 |
| 52-Wk High | $20.19 |
| 52-Wk Low | $4.22 |
Orchestra BioMed Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagSimply Wall St • about 1 month ago
Orchestra BioMed Holdings ( NASDAQ:OBIO ) Full Year 2023 Results Key Financial Results Net loss: US$49.1m (loss widened...
Share to Feed
Initiated enrollment of the BACKBEAT global pivotal study evaluating AVIM therapy (also known as BackBeat Cardiac Neuromodulation Therapy) in hypertensive pacemaker patients in collaboration with...
David Pacitti is currently the President of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers; formerly Division Vice President of U.S. Commercial Operations, Sales...
New pharmacokinetic data demonstrate Virtue SAB enables extended release of sirolimus above required tissue concentrations in target arterial sites without polymer degradation or detectable...
NEW HOPE, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, Orchestra BioMed or the Company ), a biomedical company accelerating high-impact technologies to...
Clinical study evaluated impact of AVIM therapy as compared to standard pacing using invasive pressure-volume loop analysis in 16 hypertensive pacemaker-indicated patients Results demonstrate...
8.9 mmHg mean reduction in 24-Hour ambulatory systolic blood pressure at average of 3.6 years from initiation of AVIM therapy in patients who participated in the MODERATO II study Orchestra BioMed is...
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO Get Free Report) saw a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling...
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO Get Free Report) saw a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling...
In trading on Monday, shares of Orchestra BioMed Holdings Inc (OBIO) crossed above their 200 day moving average of 9.38, changing hands as high as 10.01 per share. Orchestra BioMed...